-
Synthetic Biology, Genomics & Advanced Therapeutics1 month agoBiotech IPOs, CAR T safety, and pharma tariffs — a BioCentury podcast
BIOCENTURY | FINANCEBIOTECH IPOS, CAR T SAFETY, AND PHARMA TARIFFS — A BIOCENTURY PODCASTThe path to NASDAQ: Electra, ADARx and reverse mergers
-
Synthetic Biology, Genomics & Advanced Therapeutics1 month agoCircular mRNA helps cell factories make up to six times as much protein
A synthetic biology technology has been developed that converts easily degraded messenger RNA (mRNA) into a ring-shaped form inside microbial cells, increasing protein production.
-
Synthetic Biology, Genomics & Advanced Therapeutics1 month agoAdvancing Cell Therapy for Cardiovascular Disease
In this GEN webinar, our expert speaker Joshua Michael Hare, MD, will examine how therapeutically relevant research is helping shape the development of cell therapies for...
-
Synthetic Biology, Genomics & Advanced Therapeutics1 month agoEmerging Trends in Fluid Transfers and Freeze-Thaw Workflows
In this GEN webinar, our expert speakers will discuss the latest trends, challenges, and innovations shaping fluid transfer and freeze-thaw workflows. The post Emerging Trends in...
-
Synthetic Biology, Genomics & Advanced Therapeutics1 month agoBeacon eye gene therapy hits mark in late-stage study
Beacon claimed the findings represent the first time a treatment for X-linked retinitis pigmentosa, a rare and potentially blinding condition, met its main goal in a...
-
Synthetic Biology, Genomics & Advanced Therapeutics1 month agoFatal toxicities test autoimmune CAR T’s safety thesis
BIOCENTURY | PRODUCT DEVELOPMENTFATAL TOXICITIES TEST AUTOIMMUNE CAR T’S SAFETY THESISAutoimmune CAR T developers point to rapid manufacturing, construct design, and patient biology as potential determinants...
-
Synthetic Biology, Genomics & Advanced Therapeutics1 month agoDiscovery of CRISPR’s long lost ancestor may expand gene-editing toolkit
CRISPR may be a powerful technology for gene editing, but the system existed in bacteria long before scientists began using it. For billions of years, CRISPR...
-
Synthetic Biology, Genomics & Advanced Therapeutics1 month agoThe Saga of Sickle Cell Disease
In his new book Curved Air, Kevin Davies, PhD, portrays the fascinating story of sickle cell disease, from its origins in sub-Saharan Africa to advances in...
-
Synthetic Biology, Genomics & Advanced Therapeutics1 month agoUltragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug
Ultragenyx’s second gene therapy approval since August gives it another sellable voucher. Elsewhere, Roche declared success in a blood cancer trial and a cell therapy maker is...
-
Synthetic Biology, Genomics & Advanced Therapeutics1 month agoNew bioinformatics tools help identify pathogenic variants in the genome
Structural variants and so-called tandem repeats are individual differences in the human genome. They are increasingly linked to diseases, but analyzing and interpreting them poses challenges...
Genprex bets on a one-time gene therapy for diabetes (Part 3 of 3)
LncRNA SBF2-AS1 Worsens Heart Injury After Attack via miR-149-5p/PHLPP2 Axis
Stigmatizing language found in over half of primary care patient records
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
